August 2018 FDA Recall Drug by Pfizer Inc.
D-1184-2018 - Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point

This Class III drug recall was voluntarily initiated by Pfizer Inc. on August 28, 2018 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification stability testing results at the 18 month time point. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1184-2018

Reason for Recall
Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point
Initiated
08-28-2018
Reported
09-19-2018
Quantity
1,580 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01

Batch or Lot Expiration Information

Lot# Lot: DP602, 10/2018